Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant

Publication date: Available online 5 December 2015
Source:Vaccine
Author(s): Masayuki Hayashi, Taiki Aoshi, Yasumichi Kogai, Daisuke Nomi, Yasunari Haseda, Etsushi Kuroda, Kouji Kobiyama, Ken J. Ishii
Various particles such as Alum or silica are known to act as an adjuvant if co-administered with vaccine antigens. Several reports have demonstrated that the adjuvanticity is strongly affected by the physicochemical properties of particles such as the size, shape and surface charge, although the required properties and its relationship to the adjuvanticity are still controversial. Hydroxyapatite particle (HAp) composed of calcium phosphate has been shown to work as adjuvant in mice. However, the properties of HAp required for the adjuvanticity have not been fully characterized yet. In this study, we examined the role of size or shape of HAps in the antibody responses after immunization with antigen. HAps whose diameter ranging between 100 and 400nm provided significantly higher antibody responses than smaller or larger ones. By comparison between sphere and rod shaped HAps, rod shaped HAps induced stronger inflammasome-dependent IL-1β production than the sphere shaped ones in vitro. However, sphere- and rod-shaped HAp elicited comparable antibody response in WT mice. Vice versa, Nlrp3^−/−, Asc^−/− or Caspase1^−/− mice provided comparable level of antibody responses to HAp adjuvanted vaccination. Collectively, our results demonstrated that the size rather than shape is a more critical property, and IL-1β production via NLRP3 inflammasome is dispensable for the adjuvanticity of HAps in mice.



from #Medicine via ola Kala on Inoreader http://ift.tt/1TtDgSW
via IFTTT